Women with HIV may experience earlier menopause, heavier periods, and more vaginal infections. Transgender women with HIV face challenges, such as concerns about treatment interactions with ...

HIV infection rates may be five times higher than thought in black urban women. March 9, 2012— -- The HIV rate among black women living in some U.S. cities is the same rate as that of some ...

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV. But during a recent visit, the ...

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of ...

A new study found that the HIV treatment lenacapavir (Sunlenca) was completely effective at preventing HIV infection in women. Lenacapavir is administered as a twice-a-year shot. The drugmaker, Gilead ...

Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa. The twice-yearly ...

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Alexis Perkins thought her OB-GYN's ...